Drug intelligence / Profile preview

inosine monophosphate

Development stage
Preclinical
Lead developer
Tohoku University
Modality
Small Molecules
Administration
Oral
01

Overview

Inosine monophosphate (IMP), also known as inosinic acid, is a purine nucleotide that serves as a key intermediate in purine metabolism and a precursor to adenosine monophosphate (AMP) and guanosine monophosphate (GMP). In pharmacology and sensory biology, IMP is well-characterized as a potent positive allosteric modulator (PAM) of the umami taste receptor, a G protein-coupled receptor (GPCR) heterodimer composed of TAS1R1 and TAS1R3. While traditionally known as a flavor enhancer in the food industry, recent research has identified its presence and function in non-gustatory tissues. Specifically, studies have demonstrated that IMP, in combination with glutamate, can activate Gi-coupled umami receptors in human airway smooth muscle (HASM) cells. This activation leads to the inhibition of EGF-induced cell proliferation by reducing cAMP production and suppressing the phosphorylation of Akt and ERK pathways. These findings suggest that IMP may have therapeutic potential in modulating airway remodeling associated with chronic inflammatory respiratory diseases such as asthma.

Other names
inosinic acid5'-inosinic acidIMP
02

Targets

TAS1R3 (Sweet taste receptor T1R3 subunit)TAS1R1 (Taste receptor type 1 member 1)

Beyond the preview

Go deeper on inosine monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inosine monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call